All CE Courses | POWER-PAK C.E.®
Advertisement

Sort CE Courses


Pharmacists = Pharmacists     Pharmacy Technicians = Pharmacy Technicians

CE Articles

FREE Pharmacists The Impacts of Biosimilars on Pharmacists: Implications of the Evidence on Treatment Choices

Supporter: Boehringer Ingelheim Pharmaceuticals, Inc.
Accreditations/Hours:
ACPE / Pharm / 1.50 , ACPE / Other / 1.50
Web Publication: 2/10/2016
Expiration: 2/28/2017
Topic: Pharmacology , Pharmacy Practice , Biosimilars

FREE Pharmacists Optimizing Outcomes in Invasive Fungal Disease: Interdisciplinary Perspectives

Supporter: Astellas and Merck & Co., Inc. , Gilead Sciences Europe, LTD , T2 Biosystems , MiraVista Diagnostics , Viracor-IBT Laboratories
Accreditations/Hours:
ACPE / Pharm / 2.00 , ACPE / Other / 2.00
Web Publication: 1/31/2016
Expiration: 1/31/2017
Topic: Critical Care , HIV/AIDS , Infectious Disease , Oncology , Internal Medicine , Immunology , Managed Care

FREE Pharmacists Use of Nimodipine in Subarachnoid Hemorrhage: A Review

Supporter: Arbor Pharmaceuticals
Accreditations/Hours:
ACPE / Pharm / 2.00 , ACPE / Other / 2.00
Web Publication: 1/29/2016
Expiration: 1/31/2018
Topic: Critical Care , Hematology , Neurology , Internal Medicine , Managed Care , Long Term Care

FREE Pharmacists Team-Based Approaches to Help Older Adults With Type 2 Diabetes Achieve Individualized Glycemic Goals

Supporter: Merck & Co., Inc , Novo Nordisk Inc. , Takeda
Accreditations/Hours:
ACPE / Pharm / 1.00 , ACPE / Other / 1.00
Web Publication: 1/29/2016
Expiration: 1/29/2017
Topic: Diabetes , Endocrinology , Primary Care

FREE Pharmacists Addressing Hypoglycemia in Type 2 Diabetes Mellitus: The Pharmacists' Role in Optimizing Patient Outcomes

Supporter: Novo Nordisk Inc. , Sanofi US
Accreditations/Hours:
ACPE / Pharm / 1.50 , ACPE / Other / 1.50
Web Publication: 1/29/2016
Expiration: 1/31/2017
Topic: Pharmacology , Diabetes , Endocrinology , Specialty Pharmacy , Managed Care

FREE Pharmacists Managed Care and Specialty Pharmacist Perspectives in Hepatitis C: A 2016 Update - HCV Treatment Assessment: Opportunities for Individualized Care – Case 1

Supporter: Merck & Co., Inc
Accreditations/Hours:
ACPE / Pharm / 0.50 , ACPE / Other / 0.50
Web Publication: 1/15/2016
Expiration: 1/15/2017
Topic: Infectious Disease , Internal Medicine , Managed Care

First Previous Next Last 
Showing 1 to 6 (of 126 records)